Sign Up to like & get recommendations! 3
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.10877
Abstract: This secondary analysis of a randomized clinical trial investigates the relative effectiveness and safety of the sodium-glucose cotransporter-2 inhibitor dapagliflozin for Black vs White patients with chronic kidney disease (CKD) in North and South America. read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5796
Abstract: The effectiveness and safety of immune checkpoint inhibitor (ICI) monotherapy in advanced upper tract urothelial carcinoma (UTUC) is less reported. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30099
Abstract: To assess the effectiveness and safety of bivalirudin compared with heparin monotherapy in elderly patients undergoing percutaneous coronary intervention (PCI). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14249
Abstract: This systematic review evaluated the clinical effectiveness and safety of subcutaneous implantable cardioverter‐defibrillator (S‐ICD) in patients at an increased risk of sudden cardiac death and with an ICD indication for primary or secondary prevention. A… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Journal of the International AIDS Society"
DOI: 10.1002/jia2.26037
Abstract: Tenofovir alafenamide (TAF) is approved for paediatric use in fixed‐dose combination tablets, but efficacy and safety data in children are limited. We conducted a systematic review on the efficacy/effectiveness and safety of TAF in infants,… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Journal of medical virology"
DOI: 10.1002/jmv.27469
Abstract: BACKGROUND Ivermectin has been found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. It is unknown whether this inhibition of SARS-CoV-2 replication correlates with improved clinical outcomes. OBJECTIVE To assess the… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12333
Abstract: Recent studies have demonstrated the feasibility of uninterrupted direct oral anticoagulants (DOACs) with a temporary switch to dabigatran (“dabigatran bridge”) for atrial fibrillation (AF) ablation. We compared the effectiveness and safety between uninterrupted DOACs with… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Microsurgery"
DOI: 10.1002/micr.30895
Abstract: Digital replants and revascularization (DRV) have been performed since the 1960s but there are no recognized standard peri‐operative anticoagulation practices. A narrative systematic review of the clinical effectiveness and safety of therapeutic peri‐operative unfractionated heparin… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-018-4514-5
Abstract: PurposeTo assess the effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren®) in addition to complex decongestive therapy (CDT) on the management of patients with a breast cancer-related lymphedema (BCRL).MethodsFifty outpatients (average… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Rheumatology"
DOI: 10.1007/s10067-017-3953-6
Abstract: The current prospective observational study aimed to evaluate the long-term (24 months), real-life effectiveness of ustekinumab in psoriatic arthritis (PsA). Consecutive patients with moderate-severe PsA and active psoriasis who begun ustekinumab treatment were evaluated prospectively (January… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Neurological Sciences"
DOI: 10.1007/s10072-020-04726-6
Abstract: Fingolimod, an oral sphingosine 1-phosphate receptor modulator, is approved by EMA for relapsing-remitting multiple sclerosis (RRMS). To assess the effectiveness and safety of fingolimod in patients with RRMS in real-world clinical practice in Portugal. Retrospective,… read more here.